NAC vs GSH: Which Door's Evidence Do You Trust?
Different molecules taking different doors to the same destination — the files side by side at one standard, and the emergency-room pedigree not borrowed for Tuesday capsules.
At a glance
- Not comparable milligrams: precursor (NAC→cysteine) vs finished molecule (GSH direct)
- NAC's file: serious clinical pedigree · more inferential as a daily supplement · no claims either
- GSH's file: the direct six-month stores trial — the route's own evidence
- Together: permitted, thin case — pick one route, run it properly
Why the milligram comparison misleads — two doors to one pool
The search phrase invites a numbers race and the honest answer disqualifies it: NAC 600mg and glutathione 500mg aren't rival doses of one thing but different molecules taking different doors to the same destination. NAC (N-acetylcysteine) is precursor strategy — a stabilised cysteine delivery vehicle, cysteine being the rate-limiting amino acid in your cells' own glutathione synthesis, so 600mg of NAC is raw material trusting your machinery to build the finished product; oral GSH is finished-molecule strategy — 500mg of the assembled tripeptide, the route the foundational six-month trial tested directly and found repleting stores (that finding, the absorption history it settled). Same pool, two doors — which reframes the buying question from 'which number is bigger' to 'which route's evidence do you trust for your purpose', the comparison this cluster's existing NAC page opened and this page completes at the dose level.
The files side by side — pedigrees kept in their lanes
NAC's card, written with the respect its history earns and the precision its marketing skips: as clinical medicine, decades deep — the established hospital antidote for paracetamol overdose (working precisely by restoring glutathione, the fact that powers the whole precursor logic) and a long mucolytic prescribing history; as a daily supplement for healthy adults, more inferential — the precursor mechanism plus scattered studies across varied endpoints, without a direct healthy-adult stores-repletion trial of the kind oral GSH has, and with zero authorised food claims (a status both molecules share — the spine applies to precursors too). GSH's card at the same standard: the six-month trial is the route's own evidence — stores rising on the actual supplemented molecule — with its own honest limits (no felt effects, months-long clock, reversion after stopping). The lane-keeping this page insists on: NAC's emergency-room pedigree describes overdose medicine at clinical doses, not your Tuesday capsule — borrowing it as supplement-context proof is the same move as borrowing IV-drip contexts for oral products, and this cluster declines it in both directions (that page's territory).
Futuro Labs Glutathione
£22.99 for 30-day supply · 77p per day
Pros
- 500mg reduced glutathione (GSH) per serving — the active form
- UK manufactured under GMP certification
- Single-ingredient, vegan, no fillers
- Independently lab tested — microbiology and heavy metals
- ~77p per day vs £1.20-1.80/day for liposomal formats
Cons
- Capsule format — no liposomal delivery system
- Newer brand versus heritage names like Solgar
Available from: Amazon UK — £22.99
The router, the together question, and the close
Choosing honestly: the direct-evidence buyer — oral GSH's stores trial is the category's most on-point finding, and Futuro Labs Glutathione runs that route as tested: 500mg reduced GSH daily, single-ingredient, independently tested, £22.99/30 days at ~77p, judged on the 3-6 month curve (the clock, the record); the precursor-logic buyer — NAC's mechanism case plus lower typical pricing is a legitimate position taken knowingly, with the inferential gap owned rather than papered; the together question — permitted (no interaction concern) but thin: both routes feed one pool, the trials tested each alone, and doubling doors mostly doubles cost while wrecking attribution — this cluster's default is pick one, run it properly, let the 12-week review adjudicate (the review's page). Constants regardless of door: production inputs first (protein supplies cysteine before any capsule does — the hierarchy), gates always (pregnancy/breastfeeding → medical advice; prescription medication → pharmacist minute, NAC included — the routing), and the closing calibration: two honest doors, one quiet pool, and no milligram race worth running.
Frequently asked questions
NAC 600mg or glutathione 500mg — which is better?
The milligrams aren't comparable — different molecules, different routes: NAC 600mg supplies cysteine (the rate-limiting building block) for your cells to synthesise their own glutathione; GSH 500mg supplies the finished molecule the six-month stores trial tested directly. Precursor logic versus finished-molecule logic — both legitimate, differently evidenced, and the honest choice follows which file you trust for your purpose.
What's NAC's actual evidence?
A serious file, honestly split: as clinical medicine, decades deep — the established paracetamol-overdose antidote and a long mucolytic history; as a daily supplement for healthy adults, more inferential — precursor logic plus scattered studies, without the direct stores-repletion trial oral GSH has, and without authorised food claims (like glutathione, NAC holds none). Respect the clinical pedigree; don't let it stand in for supplement-context proof.
Can you take NAC and glutathione together?
You can — no interaction concern — but the case is thin: both feed the same pool by different doors, the trials tested each alone, and running both mostly doubles cost while muddying attribution. This cluster's default: pick one route, run it properly on its clock, and let the 12-week review decide if it stays.